Thomas R. Cate

4.3k total citations · 1 hit paper
46 papers, 3.2k citations indexed

About

Thomas R. Cate is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Thomas R. Cate has authored 46 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 16 papers in Immunology and 9 papers in Infectious Diseases. Recurrent topics in Thomas R. Cate's work include Influenza Virus Research Studies (27 papers), Respiratory viral infections research (25 papers) and Immune Response and Inflammation (9 papers). Thomas R. Cate is often cited by papers focused on Influenza Virus Research Studies (27 papers), Respiratory viral infections research (25 papers) and Immune Response and Inflammation (9 papers). Thomas R. Cate collaborates with scholars based in United States, Canada and Australia. Thomas R. Cate's co-authors include Robert B. Couch, Robert L. Atmar, Stephen B. Greenberg, Jeffrey N. Weiser, Tera L. McCool, Philip R. Wyde, Wendy A. Keitel, Joan Wilson, Charles E. Stager and Richard J. Duma and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Thomas R. Cate

45 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

1979 631 citations Thomas R. Cate et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas R. Cate United States	31	2.4k	1.0k	697	278	274	46	3.2k
H. J. Koornhof South Africa	33	1.7k 0.7×	1.2k 1.2×	207 0.3×	290 1.0×	492 1.8×	93	3.2k
I. W. Fong Canada	31	1.6k 0.7×	1.0k 1.0×	368 0.5×	322 1.2×	659 2.4×	99	3.5k
Gary J. Noel United States	32	1.1k 0.5×	1.2k 1.2×	601 0.9×	353 1.3×	253 0.9×	88	3.2k
Richard F. Jacobs United States	39	3.3k 1.4×	2.3k 2.2×	388 0.6×	344 1.2×	363 1.3×	136	5.4k
Victor Fainstein United States	39	1.5k 0.6×	1.6k 1.6×	247 0.4×	508 1.8×	190 0.7×	95	4.1k
James I. Ito United States	28	2.4k 1.0×	2.0k 2.0×	307 0.4×	413 1.5×	379 1.4×	57	5.4k
Melissa D. Johnson United States	29	1.9k 0.8×	2.1k 2.1×	376 0.5×	348 1.3×	124 0.5×	92	3.3k
José Marı́a Eiros Bouza Spain	28	1.5k 0.6×	1.1k 1.0×	440 0.6×	500 1.8×	69 0.3×	301	3.3k
Masafumi Seki Japan	27	1.2k 0.5×	789 0.8×	315 0.5×	453 1.6×	149 0.5×	155	2.5k
Amy Weintrob United States	34	1.6k 0.7×	1.6k 1.5×	524 0.8×	288 1.0×	137 0.5×	98	4.0k

Countries citing papers authored by Thomas R. Cate

Since Specialization

Citations

This map shows the geographic impact of Thomas R. Cate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas R. Cate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas R. Cate more than expected).

Fields of papers citing papers by Thomas R. Cate

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas R. Cate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas R. Cate. The network helps show where Thomas R. Cate may publish in the future.

Co-authorship network of co-authors of Thomas R. Cate

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas R. Cate. A scholar is included among the top collaborators of Thomas R. Cate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas R. Cate. Thomas R. Cate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Knight, Vernon, Peter J. Gerone, Robert B. Couch, et al.. (2015). Studies in Volunteers with Respiratory Viral Agents1. American Review of Respiratory Disease.

Atmar, Robert L., Wendy A. Keitel, John M. Quarles, et al.. (2011). Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine. Vaccine. 29(45). 8066–8072. 10 indexed citations

Frenck, Robert W., Robert B. Belshe, Rebecca C. Brady, et al.. (2011). Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults. Vaccine. 29(34). 5666–5674. 52 indexed citations

Cate, Thomas R., Diane Niño, Patricia Winokur, et al.. (2009). A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects. Vaccine. 28(9). 2076–2079. 101 indexed citations

Patel, Shital M., Robert L. Atmar, Hana M. El Sahly, Thomas R. Cate, & Wendy A. Keitel. (2009). A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route. Vaccine. 28(17). 3025–3029. 21 indexed citations

Couch, Robert B., Robert L. Atmar, Thomas R. Cate, et al.. (2009). Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans. Vaccine. 27(39). 5344–5348. 35 indexed citations

Talbot, H. Keipp, Wendy A. Keitel, Thomas R. Cate, et al.. (2008). Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. Vaccine. 26(32). 4057–4061. 31 indexed citations

Couch, Robert B., Patricia Winokur, Rebecca C. Brady, et al.. (2007). Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine. 25(44). 7656–7663. 134 indexed citations

Atmar, Robert L., et al.. (2007). A dose–response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults. Vaccine. 25(29). 5367–5373. 52 indexed citations

10.

Keitel, Wendy A., Robert L. Atmar, Thomas R. Cate, et al.. (2006). Safety of High Doses of Influenza Vaccine and Effect on Antibody Responses in Elderly Persons. Archives of Internal Medicine. 166(10). 1121–1121. 134 indexed citations

11.

McCool, Tera L., et al.. (2002). The Immune Response to Pneumococcal Proteins during Experimental Human Carriage. The Journal of Experimental Medicine. 195(3). 359–365. 206 indexed citations

12.

Keitel, Wendy A., Thomas R. Cate, Diane Niño, et al.. (2001). Immunization against Influenza: Comparison of Various Topical and Parenteral Regimens Containing Inactivated and/or Live Attenuated Vaccines in Healthy Adults. The Journal of Infectious Diseases. 183(2). 329–332. 26 indexed citations

13.

Hoe, Nancy P., Parichher Kordari, Robert L. Cole, et al.. (2000). Human Immune Response to Streptococcal Inhibitor of Complement, a Serotype M1 Group AStreptococcusExtracellular Protein Involved in Epidemics. The Journal of Infectious Diseases. 182(5). 1425–1436. 33 indexed citations

14.

Keitel, Wendy A., et al.. (1997). Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine. 15(10). 1114–1122. 169 indexed citations

15.

Couch, Robert B., Wendy A. Keitel, & Thomas R. Cate. (1997). Improvement of Inactivated Influenza Virus Vaccines. The Journal of Infectious Diseases. 176(s1). S38–S44. 55 indexed citations

16.

Mbawuike, Innocent N., Pedro A. Piedra, Thomas R. Cate, & Robert B. Couch. (1996). Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine. Journal of Medical Virology. 50(2). 105–111. 32 indexed citations

17.

Mbawuike, Innocent N., et al.. (1994). Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein. Vaccine. 12(14). 1340–1348. 18 indexed citations

18.

Genta, Robert M., et al.. (1993). In situ hybridization and immunohistochemical analysis of cytomegalovirus-associated ileal perforation. Gastroenterology. 104(6). 1822–1827. 28 indexed citations

19.

Keitel, Wendy A., Robert B. Couch, John M. Quarles, et al.. (1993). Trivalent Attenuated Cold-Adapted Influenza Virus Vaccine: Reduced Viral Shedding and Serum Antibody Responses in Susceptible Adults. The Journal of Infectious Diseases. 167(2). 305–311. 35 indexed citations

20.

Murphy, Brian R., R. Gordon Douglas, Robert F. Betts, et al.. (1980). Evaluation of Influenza A/Hong Kong/123/77 (H1N1) ts -1A2 and Cold-Adapted Recombinant Viruses in Seronegative Adult Volunteers. Infection and Immunity. 29(2). 348–355. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact